UNIGENE LABORATORIES INC Operating Cash Flow
UNIGENE LABORATORIES INC reported Operating Cash Flow of -$3.41 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-05-14
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was -$3.41M.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was -$56.52K.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$1.40M.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$1.60M, a 195.29% decline year-over-year.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for fiscal 2012 was -$3.18M.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for fiscal 2011 was -$6.77M.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for fiscal 2010 was -$1.67M.
- UNIGENE LABORATORIES INC net cash provided by (used in) operating activities for fiscal 2009 was -$11.29M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$3.41M 10-Q · filed 2013-05-14 | -$3.46M derived: sum of 2 quarters · filed 2013-05-14 | -$4.86M derived: sum of 3 quarters · filed 2013-05-14 | -$6.47M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | -$56.52K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.46M derived: sum of 2 quarters · filed 2013-03-15 | -$3.06M derived: sum of 3 quarters · filed 2013-03-15 | -$3.18M 10-K · filed 2013-03-15 |
| 2012-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | -$3.01M derived: sum of 2 quarters · filed 2013-01-31 | -$3.12M 10-Q · filed 2013-01-31 | -$5.26M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | -$1.60M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31 | -$1.72M 10-Q/A · filed 2013-01-31 | -$3.86M derived: sum of 3 quarters · filed 2013-05-14 | -$6.18M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | -$115.01K 10-Q · filed 2013-05-14 | -$2.25M derived: sum of 2 quarters · filed 2013-05-14 | -$4.58M derived: sum of 3 quarters · filed 2013-05-14 | -$2.89M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$4.46M derived: sum of 2 quarters · filed 2013-03-15 | -$2.78M derived: sum of 3 quarters · filed 2013-03-15 | -$6.77M 10-K · filed 2013-03-15 |
| 2011-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | -$637.86K derived: sum of 2 quarters · filed 2013-01-31 | -$4.63M 10-Q · filed 2013-01-31 | -$687.53K derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $1.68M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-01-31 | -$2.31M 10-Q/A · filed 2013-01-31 | $1.63M derived: sum of 3 quarters · filed 2013-03-15 | -$357.56K derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$3.99M 10-Q/A · filed 2013-01-31 | -$49.67K derived: sum of 2 quarters · filed 2013-03-15 | -$2.04M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.95M derived: sum of 2 quarters · filed 2013-03-15 | -$1.67M 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$5.61M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$3.62M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$11.29M 10-K/A · filed 2013-01-31 |